Trial Profile
An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone Enanthate After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone enanthate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Antares Pharma
- 14 Apr 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 25 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 11 Sep 2014 New trial record